Several studies have confirmed these mechanisms and investigated stroke biomarkers, such as IL-6, S100B, NSE, D-Dimer and GFAP in T2DM populations, demonstrating their relevance to stroke risk. The gene discussed is GFAP; the disease is stroke disorder.